Direct mecA polymerase chain reaction testing of blood culture bottles growing Gram-positive cocci and the clinical potential in optimizing antibiotic therapy for staphylococcal bacteremia

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 1, 2013, Pages 37-41

  Wang, Bing ^a   Jessamine, Peter ^a   Desjardins, Marc ^a   Toye, Baldwin ^a   Ramotar, Karam ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

AmecA PCR; Antibiotic therapy; Blood culture; Gram positive cocci

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CLOXACILLIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS INFECTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS; YOUNG ADULT;

EID: 84870767281     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.09.014     Document Type: Article

References (31)

1. Barenfanger J., Drake C., et al. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999, 37(5):1415-1418.
2. Carroll K.C. Rapid diagnostics for methicillin-resistant Staphylococcus aureus: current status. Mol Diagn Ther 2008, 12(1):15-24.
3. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility test (M02-A10). Wayne, PA: CLSI; 2008.
4. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 19th informational supplement (M100-S19). Wayne, PA: CLSI; 2006.
5. Cosgrove S.E., Fowler V.G. Management of methicillin-resistant Staphylococcus bacteremia. Clin Infect Dis 2008, 46(Suppl 5):S386-S393.
6. Cosgrove S.E., Sakoulas G., et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36(1):53-59.
7. Deresinski S. Counterpoint: vancomycin and Staphylococcus aureus-an antibiotic enters obsolescence. Clin Infect Dis 2007, 44(12):1543-1548.
8. Frye A., Baker C.A., et al. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol 2011, 50(1):127-133.
9. Gradelski E., Valera L., et al. Correlation between genotype and phenotypic categorization of staphylococci based on methicillin susceptibility and resistance. J Clin Microbiol 2001, 39(8):2961-2963.
10. Grobner S., Kempf V.A. Rapid detection of methicillin-resistant staphylococci by real-time PCR directly from positive blood culture bottles. Eur J Clin Microbiol Infect Dis 2007, 26(10):751-754.
11. Hallin M., Maes N., et al. Clinical impact of a PCR assay for identification of Staphylococcus aureus and determination of methicillin resistance directly from blood cultures. J Clin Microbiol 2003, 41(8):3942-3944.
12. Horstkotte M.A., Knobloch J.K., et al. Evaluation of the BD PHOENIX automated microbiology system for detection of methicillin resistance in coagulase-negative staphylococci. J Clin Microbiol 2004, 42(11):5041-5046.
13. Horstkotte M.A., Knobloch J.K.M., et al. Rapid detection of methicillin resistance in coagulase-negative staphylococci with the VITEK 2 system. J Clin Microbiol 2002, 40(9):3291-3295.
14. Hussain Z., Stoakes L., et al. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J Clin Microbiol 2000, 38(2):752-754.
15. Ibrahim E.H., Sherman G., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118(1):146-155.
16. Clinical microbiology procedures handbook 1992, Vol. 1:1.20.11-1.20.12. American Society for Microbiology, Washington, DC. H.D. Isenberg (Ed.).
17. Jang H., Kim S., Kim K., Kim C., Lee S., Song K., et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infec Dis 2009, 49(3):395-401.
18. John M.A., Burden J., et al. Comparison of three phenotypic techniques for detection of methicillin resistance in Staphylococcus spp. reveals a species-dependent performance. J Antimicrob Chemother 2009, 63(3):493-496.
19. Kim S.H., Kim K.H., et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008, 52(1):192-197.
20. Kollef M.H., Sherman G., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115(2):462-474.
21. Liu H., Buescher G., et al. Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains. Eur J Clin Microbiol Infect Dis 1990, 9(10):717-724.
22. Micek S.T. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2007, 45(Suppl 3):S184-S190.
23. Murray P.R., Baron E.J., et al. Manual of clinical microbiology 2007, Vol. 1:390-411. ASM Press, Washington, DC. 9th ed.
24. Pittet D., Tarara D., Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271(20):1598-1601.
25. Rosenthal V.D., Maki D.G., et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 2010, 38(2):95-104 e2.
26. Ruimy R., Dos-Santos M., et al. Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered Gram-positive cocci on direct smears. J Clin Microbiol 2008, 46(6):2045-2051.
27. Schramm G.E., Johnson J.A., et al. Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 2006, 34(8):2069-2074.
28. Shrestha N.K., Tuohy M.J., et al. Rapid identification of Staphylococcus aureus and the mecA gene from BacT/ALERT blood culture bottles by using the LightCycler system. J Clin Microbiol 2002, 40(7):2659-2661.
29. Simor A.E., Gilbert N.L., et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007. Infect Control Hosp Epidemiol 2010, 31(4):348-356.
30. Stryjewski M.E., Szczech L.A., et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007, 44(2):190-196.
31. Swenson J.M., Williams P.P., et al. Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms. J Clin Microbiol 2001, 39(10):3785-3788.